ReviewTherapeutic delivery2025
Ultrasound-triggered drug delivery: recent developments and opportunities.
Review in Therapeutic delivery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- A ROS-responsive core-shell microneedle platform integrating sonodynamic gas antibacterial therapy and modulating immunity for diabetic wound healing.Journal of nanobiotechnology · 2026Article
- Ultrasound-responsive nanoplatforms for cancer immunotherapy: engineering spatiotemporal immune activation in the tumor microenvironment.Frontiers in immunology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
While ultrasound-based medical imaging is widely used in clinics, ultrasound-triggered drug delivery represents an emerging modality that takes advantage of the high tissue penetrability, general safety, and high clinical accessibility of ultrasound to solve key challenges around localized drug delivery. In this review, we analyze emerging trends in the design of drug delivery vehicles activated using different ultrasound effects ranging from cavitation, mechanical stimulation, localized heating, reactive oxygen species generation, localized gas generation, and/or penetration enhancement. In particular, we focus on vehicle designs that enable delayed burst release, sustained release, and pulsatile on-off release of drugs locally at the targeted ultrasound site, each of which has direct applications for treating specific diseases. Vehicles in which ultrasound-mediated drug release kinetics control is synergistically coupled with other therapeutic benefits of ultrasound are highlighted. Finally, we discuss key barriers to the practical translation of ultrasound-triggered drug delivery vehicles into the clinic, aiming to motivate the design of scalable and reproducible ultrasound-triggered drug delivery vehicles that can have real-world patient impact.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.